LEXINGTON, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today praised actions taken by the U.S. Centers for Disease Control and Prevention (CDC) aimed at optimizing hospital sepsis programs in the United States. The…Read More
T2 Biosystems Praises CDCs Actions Aimed at Optimizing US Hospital Sepsis Programs
